162 related articles for article (PubMed ID: 21245204)
1. Chelation of cadmium by combining deferasirox and deferiprone in rats.
Jamilaldin Fatemi S; Saljooghi AS; Balooch FD; Iranmanesh M; Golbafan MR
Toxicol Ind Health; 2011 May; 27(4):371-7. PubMed ID: 21245204
[TBL] [Abstract][Full Text] [Related]
2. Chelation of chromium(VI) by combining deferasirox and deferiprone in rats.
Iranmanesh M; Fatemi SJ; Ebrahimpour R; Dahooee Balooch F
Biometals; 2013 Jun; 26(3):465-71. PubMed ID: 23670101
[TBL] [Abstract][Full Text] [Related]
3. Chelation of bismuth by combining desferrioxamine and deferiprone in rats.
Tubafard S; Fatemi SJ
Toxicol Ind Health; 2008 May; 24(4):235-40. PubMed ID: 19022876
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of Deferasirox for removal of cadmium ions in rat.
Saljooghi AS; Fatemi SJ
Biometals; 2010 Aug; 23(4):707-12. PubMed ID: 20401682
[TBL] [Abstract][Full Text] [Related]
5. Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats.
Fatemi SJ; Saljooghi AS; Balooch FD; Iranmanesh M; Golbafan MR
Toxicol Ind Health; 2012 Feb; 28(1):35-41. PubMed ID: 22134990
[TBL] [Abstract][Full Text] [Related]
6. Chelation of aluminum by combining deferasirox and deferiprone in rats.
Saljooghi AS
Toxicol Ind Health; 2012 Sep; 28(8):740-5. PubMed ID: 22025507
[TBL] [Abstract][Full Text] [Related]
7. Chelation of thallium by combining deferasirox and desferrioxamine in rats.
Saljooghi AS; Babaie M; Mendi FD; Zahmati M; Saljooghi ZS
Toxicol Ind Health; 2016 Jan; 32(1):83-8. PubMed ID: 24021432
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mercury vapor toxicity by combining deferasirox and deferiprone in rats.
Iranmanesh M; Fatemi SJ; Golbafan MR; Balooch FD
Biometals; 2013 Oct; 26(5):783-8. PubMed ID: 23846228
[TBL] [Abstract][Full Text] [Related]
9. Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.
Voskaridou E; Christoulas D; Terpos E
Br J Haematol; 2011 Sep; 154(5):654-6. PubMed ID: 21615376
[No Abstract] [Full Text] [Related]
10. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox.
Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):1-15. PubMed ID: 18274978
[TBL] [Abstract][Full Text] [Related]
11. Combined chelation of lead (II) by deferasirox and deferiprone in rats as biological model.
Balooch FD; Fatemi SJ; Iranmanesh M
Biometals; 2014 Feb; 27(1):89-95. PubMed ID: 24309925
[TBL] [Abstract][Full Text] [Related]
12. The effects of deferiprone and deferasirox on the structure and function of beta-thalassemia hemoglobin.
Moosavi-Movahedi AA; Mousavy SJ; Divsalar A; Babaahmadi A; Karimian K; Shafiee A; Kamarie M; Poursasan N; Farzami B; Riazi GH; Hakimelahi GH; Tsai FY; Ahmad F; Amani M; Saboury AA
J Biomol Struct Dyn; 2009 Dec; 27(3):319-39. PubMed ID: 19795915
[TBL] [Abstract][Full Text] [Related]
13. Objectives and mechanism of iron chelation therapy.
Hershko C; Link G; Konijn AM; Cabantchik ZI
Ann N Y Acad Sci; 2005; 1054():124-35. PubMed ID: 16339658
[TBL] [Abstract][Full Text] [Related]
14. Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
Balocco M; Carrara P; Pinto V; Forni GL
Am J Hematol; 2010 Jun; 85(6):460-1. PubMed ID: 20513129
[No Abstract] [Full Text] [Related]
15. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
16. Removal of thallium by deferasirox in rats as biological model.
Saljooghi ASh; Fatemi SJ
J Appl Toxicol; 2011 Mar; 31(2):139-43. PubMed ID: 20687118
[TBL] [Abstract][Full Text] [Related]
17. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil.
Wood JC; Otto-Duessel M; Gonzalez I; Aguilar MI; Shimada H; Nick H; Nelson M; Moats R
Transl Res; 2006 Nov; 148(5):272-80. PubMed ID: 17145573
[TBL] [Abstract][Full Text] [Related]
18. Iron chelation therapy for transfusional iron overload: a swift evolution.
Musallam KM; Taher AT
Hemoglobin; 2011; 35(5-6):565-73. PubMed ID: 21910602
[TBL] [Abstract][Full Text] [Related]
19. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry.
Fischer R; Piga A; Harmatz P; Nielsen P
Ann N Y Acad Sci; 2005; 1054():350-7. PubMed ID: 16339683
[TBL] [Abstract][Full Text] [Related]
20. Deferasirox--current knowledge and future challenges.
Porter JB
Ann N Y Acad Sci; 2010 Aug; 1202():87-93. PubMed ID: 20712778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
